Human epididymis protein 4 (HE4), which is encoded by the WAP four‐disulfide core domain 2 gene, was approved by the US Food and Drug Administration in 2008 for the early diagnosis, efficacy evaluation, and relapse monitoring of patients with epithelial ovarian cancer. This evidence concerns the gene WFDC2 and ovarian carcinoma.